# Journey Medical Corp (DERM) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Journey Medical Corp's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/DERM/mda/fy2025/): filed 2026-03-26; accession 0001104659-26-034629 (https://www.sec.gov/Archives/edgar/data/1867066/000110465926034629/derm-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/DERM/mda/fy2024/): filed 2025-03-27; accession 0001410578-25-000490 (https://www.sec.gov/Archives/edgar/data/1867066/000141057825000490/derm-20241231x10k.htm)
- [FY 2023 MD&A](/company/DERM/mda/fy2023/): filed 2024-03-29; accession 0001410578-24-000347 (https://www.sec.gov/Archives/edgar/data/1867066/000141057824000347/derm-20231231x10k.htm)
- [FY 2022 MD&A](/company/DERM/mda/fy2022/): filed 2023-03-31; accession 0001410578-23-000485 (https://www.sec.gov/Archives/edgar/data/1867066/000141057823000485/derm-20221231x10k.htm)
- [FY 2021 MD&A](/company/DERM/mda/fy2021/): filed 2022-03-28; accession 0001410578-22-000558 (https://www.sec.gov/Archives/edgar/data/1867066/000141057822000558/derm-20211231x10k.htm)

Back to /company/DERM/